These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19241856)

  • 1. [High-dosage brachytherapy of prostate cancer--a technique of the future].
    Kharchenko VP; Kaprin AD; Pan'shin GA; Khmelevskiĭ EV; Milenin KN; Egorova EV; Al'bitskiĭ IA
    Vopr Onkol; 2008; 54(6):765-7. PubMed ID: 19241856
    [No Abstract]   [Full Text] [Related]  

  • 2. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of brachytherapy for radical treatment of prostate cancer].
    Pan'shin GA; Kaprin AD; Al'bitskiĭ IA; Milenin KN; Khmelevskiĭ EV
    Vopr Onkol; 2006; 52(6):663-9. PubMed ID: 17338245
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interstitial radiotherapy in the treatment of prostate cancer].
    Knüfermann H; Bruggmoser G; Wannenmacher M
    Strahlentherapie Sonderb; 1981; 76():63-9. PubMed ID: 7303126
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endocavitary irradiation of cancer of the prostate].
    Dragon V; Pache G; vo Niederhüsern W; Pellet B; Valley JF
    Rev Med Suisse Romande; 1980 Sep; 100(9):755-62. PubMed ID: 7455475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of radiotherapy in the treatment of cancer of the prostate].
    Van Houtte P; Henry J
    Rev Med Brux; 1984 Oct; 5(8):533-9. PubMed ID: 6505454
    [No Abstract]   [Full Text] [Related]  

  • 7. 5 year clinical outcomes for organ confined low, intermediate, and high risk prostate cancer treated with PSI +/- ERT: the Christiana Health Care experience.
    Benge B; Donavanik V; Sammons S; Glick A; Sarkar A; Townsend M; Hanlon A; Koprowski P; Raben A; Kattepogu K
    Del Med J; 2009 May; 81(5):189-93. PubMed ID: 19634632
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
    Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
    Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Curative radiotherapy of cancer of the prostate].
    Gérard JP; Romestaing P; Montbarbon X
    Pathol Biol (Paris); 1989 Feb; 37(2):116-7. PubMed ID: 2652057
    [No Abstract]   [Full Text] [Related]  

  • 10. Fertility after prostate brachytherapy.
    Khaksar SJ; Laing RW; Langley SE
    BJU Int; 2005 Oct; 96(6):915. PubMed ID: 16153230
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of radiotherapy of patients with cancer of the prostate].
    Aliev BM; Tkachev SI
    Vestn Rentgenol Radiol; 1987; (5):71-5. PubMed ID: 3321694
    [No Abstract]   [Full Text] [Related]  

  • 13. External or interstitial radiotherapy: what indications for the management of prostatic carcinoma?
    Cellini N
    Rays; 1993; 18(1):81-7. PubMed ID: 8356243
    [No Abstract]   [Full Text] [Related]  

  • 14. [Remote afterloading transurethral radiotherapy of prostatic cancer].
    Kigure T; Harada T; Etori K; Nishizawa O; Miyagata S; Kumazaki T; Koh D; Shimoda J; Hongoh R; Tsuchida S
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2514-9. PubMed ID: 3209920
    [No Abstract]   [Full Text] [Related]  

  • 15. [Features of high-dose brachytherapy in patients with localized prostate cancer].
    Kanaev SV; Novikov SN
    Vopr Onkol; 2013; 59(5):645-50. PubMed ID: 24260896
    [No Abstract]   [Full Text] [Related]  

  • 16. The "Golden Age" of prostate brachytherapy: a cautionary tale.
    Aronowitz JN
    Brachytherapy; 2008; 7(1):55-9. PubMed ID: 18299114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after prostate brachytherapy in patients aged 60 years and younger.
    Stone NN
    BJU Int; 2011 Jun; 107(12):1911. PubMed ID: 21623941
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating prostate cancer. Part IV: radiotherapy.
    Harv Mens Health Watch; 1999 Nov; 4(4):2-6. PubMed ID: 10521913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.